Our results may indicate that suppression of either IL‐5 or IL‐4/IL13 is insufficient and it is necessary to suppress both Type‐2 cytokines such as IL‐5 and IL‐4/IL‐13 for the improvement of asthma control. The gene discussed is IL4; the disease is asthma.